Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-14

Clinical Trial Update: Methylene Blue and Postoperative Neurocognitive Disorders [NA]

View source ↗

Summary

A completed clinical trial by Fudan University evaluated methylene blue for postoperative delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Fudan University | Conditions: Postoperative Delirium | NA | Status: COMPLETED